Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NTP Determines Formaldehyde “Known Human Carcinogen” In New Report

This article was originally published in The Rose Sheet

Executive Summary

The National Toxicology Program has included formaldehyde on its list of known human carcinogens, potentially adding to the controversy surrounding the safety of the ingredient and its use in hair-straightening products.

You may also be interested in...



In Brief

NTP Nominates Five Cosmetic Ingredients For Carcinogens Report

The National Toxicology Program nominates five substances with cosmetic uses among 20 substances it is considering adding to future editions of its Report on Carcinogens. Cocamide DEA and kava kava extract, among others, make the tentative list.

ECHA Committee Takes Lighter View On Formaldehyde Than U.S. Agencies

ECHA’s Committee for Risk Assessment adopts an opinion to classify formaldehyde as “presumed to have carcinogenic potential,” a decidedly less rigid stance than U.S. regulators, which have deemed the ingredient a “known human carcinogen.”

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel